share_log

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behbahani Ali

SEC ·  Jun 1 04:54

Summary by Futu AI

In a recent transaction, Ali Behbahani, a reporting person for CRISPR Therapeutics AG (CRSP), executed a stock transaction on May 30, 2024. The details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed. The relationship of Behbahani to the issuer was not specified in the announcement. Investors are advised to note the date of the transaction for any potential impact on the stock's performance.
In a recent transaction, Ali Behbahani, a reporting person for CRISPR Therapeutics AG (CRSP), executed a stock transaction on May 30, 2024. The details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed. The relationship of Behbahani to the issuer was not specified in the announcement. Investors are advised to note the date of the transaction for any potential impact on the stock's performance.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated